admin
December 8, 2025
Pharmaceuticals enter the environment via patient excretion, improper disposal, and manufacturing waste, prompting regulators worldwide to require environmental risk assessments (ERAs) as part of drug approvals. In an ERA, predicted environmental concentrations (PECs) of a drug are compared to ecotoxicity thresholds, often in a tiered fashion (Phase I screening followed by Phase II testing) [1]. This report analyzes ERA regulations and practice globally, from the EU and US to emerging regions in Asia, Latin America, the Middle East, and Africa. It integrates recent developments in China, India, Brazil, the Gulf Cooperation Council (GCC) countries, ASEAN nations, and African markets, alongside established frameworks (EU, US, Canada, Japan, Australia). Key findings include:
December 5, 2025
Two of the major risk factors for heart disease are high blood pressure and high blood cholesterol. If either of these numbers is high, work with your doctor to get it to a healthy range.
December 4, 2025
The University of Arizona Health Sciences recently reported that cannabis terpenes themselves — not just cannabinoids — may provide measurable pain relief and contribute to the “entourage effect.”
December 3, 2025
Project CBD recently reported a growing trend in the U.S.:
adults reducing or replacing prescription medications with cannabis, while others add cannabis on top of already complex drug regimens.
(Project CBD) This is where the story turns from wellness to risk.
